Literature DB >> 9060055

A seroepidemiologic study of Chlamydia pneumoniae, Chlamydia trachomatis and Chlamydia psittaci in different populations on the mainland of China.

A P Ni1, G Y Lin, L Yang, H Y He, C W Huang, Z J Liu, R S Wang, J S Zhang, J Y Yu, N Li, J B Wang, H Y Yang.   

Abstract

To evaluate and compare the prevalence of antibodies to 3 chlamydial species in various populations on the mainland of China, the MIF test was used to detect both serum IgG and IgM antibodies to these species in the normal population (n = 711), in poultry workers (n = 51), in female prostitutes (n = 106), in patients attending the sexually transmitted diseases clinic (n = 98), and in adult patients with pneumonia and bronchitis (n = 108). In the normal population, IgG antibodies against C. pneumoniae, C. trachomatis and C. psittaci were present in 61.5%, 9.3%, and 3.5%, respectively, and increasing with age. Prevalence and geometric mean titers (GMT) of IgG antibodies to C. trachomatis in prostitutes (54.7%) and female (55%), but not male (15.4%) sexually transmitted disease patients were significantly higher than in the normal adult female population. The prevalence indicating both previous and recent C. psittaci infections in poultry workers was no higher than in the others. The prevalence of IgG antibodies and GMT to C. pneumoniae in patients with pneumonia and bronchitis was not statistically higher than in the normal adult population. Evidence of cross-reactivities in the MIF test between different species was found in both prevalence and GMT. Serum IgM antibodies were usually absent in patients who met the serological criteria of recent C. pneumoniae infection, indicating that most of them could be considered as reinfections. On the basis of our survey, acute antibodies to C. pneumoniae by the MIF test, if they are detected, may be valuable in the diagnosis of recent C. pneumoniae infections.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9060055     DOI: 10.3109/00365549609037959

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  8 in total

1.  Male sex predominance in Chlamydia trachomatis sexually acquired reactive arthritis: are women more protected by anti-chlamydia antibodies?

Authors:  S Bas; C Scieux; T L Vischer
Journal:  Ann Rheum Dis       Date:  2001-06       Impact factor: 19.103

2.  Chlamydophila psittaci zoonotic risk assessment in a chicken and turkey slaughterhouse.

Authors:  V Dickx; T Geens; T Deschuyffeleer; L Tyberghien; T Harkinezhad; D S A Beeckman; L Braeckman; D Vanrompay
Journal:  J Clin Microbiol       Date:  2010-06-30       Impact factor: 5.948

3.  Pgp3 antibody enzyme-linked immunosorbent assay, a sensitive and specific assay for seroepidemiological analysis of Chlamydia trachomatis infection.

Authors:  Gillian S Wills; Patrick J Horner; Rosy Reynolds; Anne M Johnson; David A Muir; David W Brown; Alan Winston; Andrew J Broadbent; David Parker; Myra O McClure
Journal:  Clin Vaccine Immunol       Date:  2009-04-08

Review 4.  Chlamydial infection: the link with ocular adnexal lymphomas.

Authors:  Andrés J M Ferreri; Riccardo Dolcetti; Simone Magnino; Claudio Doglioni; Maurilio Ponzoni
Journal:  Nat Rev Clin Oncol       Date:  2009-10-06       Impact factor: 66.675

5.  Acute Chlamydia trachomatis respiratory infection in infants.

Authors:  Kamal Narain Mishra; Pankaj Bhardwaj; Anuradha Mishra; Anil Kaushik
Journal:  J Glob Infect Dis       Date:  2011-07

6.  A retrospective seroepidemiologic survey of Chlamydia pneumoniae infection in patients in Beijing between 2008 and 2017.

Authors:  Jingtao Cui; Wenjuan Yan; Hongjie Xie; Shaoxia Xu; Qiaofeng Wang; Weihong Zhang; Anping Ni
Journal:  PLoS One       Date:  2018-11-07       Impact factor: 3.240

Review 7.  Epidemiology and etiology of community-acquired pneumonia.

Authors:  Lionel A Mandell
Journal:  Infect Dis Clin North Am       Date:  2004-12       Impact factor: 5.982

8.  Presence of Chlamydophila pneumoniae DNA in blood cells is a frequent event in patients with the late stage of primary cutaneous lymphomas and with atopic dermatitis.

Authors:  Bogusław Nedoszytko; Piotr Wierzbicki; Leena Karenko; Agata Maciejewska-Radomska; Przemysław Stachewicz; Monika Zabłotna; Jolanta Gleń; Liisa Väkevä; Roman J Nowicki; Małgorzata Sokołowska-Wojdyło
Journal:  Postepy Dermatol Alergol       Date:  2018-06-18       Impact factor: 1.837

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.